Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. A Review of FDA Guidance
Year: 2010
Type: review
Authors: Erica Caveney, J. Rick Turner
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2185855791
